Stay updated with breaking news from Solid Biosciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roche Holdings AG Basel ADR (OTC: RHHBY) said Monday that it has signed a licensing agreement with Sarepta Therapeutics Inc (NASDAQ: SRPT) to acquire the commercial rights to the latter's investigational gene therapy asset SRP-9001 outside of the U.S. The asset is being evaluated in... Read More...
Solid Biosciences Inc (NASDAQ: SLDB) reported interim functional, biomarker data, and patient-reported outcome measures from its ...
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal Benzinga 12/16/2020 © Provided by Benzinga Popular Searches Anchiano Therapeutics Ltd – ADR (NASDAQ: ANCN) (announced a reverse merger with Chemomab) Arvinas Inc (NASDAQ: ARVN) Bioanalytical Systems, Inc. (NASDAQ: BASI) BioCardia Inc (NASDAQ: BCDA) BioTelemetry Inc (NASDAQ: BEAT) Frequency Therapeutics Inc (NASDAQ: FREQ) Globus Medical Inc (NYSE: GMED) Inhibrx Inc (NASDAQ: INBX) PRA Health Sciences Inc (NASDAQ: PRAH) Prevail Therapeutics Inc (NASDAQ: PRVL) (a...
Annual Changes To The Nasdaq Biotechnology Index Date 11/12/2020 Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 21, 2020. The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (Nasdaq®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The following 100 securities will be added to the Index: EXCHANGE